Breakthrough Drug for Cystic Fibrosis Priced at $300k a Year

In 2019 Vertex Pharmaceuticals received FDA approval for a ground breaking drug that treats Cystic Fibrosis. The drug, called Trikafta, is a combination of therapeutic medicines which were the first to treat CF from it's root cause. 90% of patients with CF have a genetic mutation which leads to a dysfunctional protein involved in transmembrane transport of essential ions. Due to this mutation, people with CF experience a variety of health problems, many of which can be life threatening. Prior to the release of these drugs, CF has primarily been treated symptomatically to manage the problems…